Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 268

1.

Antisense peptide-phosphorodiamidate morpholino oligomer conjugate: dose-response in mice infected with Escherichia coli.

Tilley LD, Mellbye BL, Puckett SE, Iversen PL, Geller BL.

J Antimicrob Chemother. 2007 Jan;59(1):66-73. Epub 2006 Oct 31.

PMID:
17079242
2.

Antisense phosphorodiamidate morpholino oligomer inhibits viability of Escherichia coli in pure culture and in mouse peritonitis.

Geller BL, Deere J, Tilley L, Iversen PL.

J Antimicrob Chemother. 2005 Jun;55(6):983-8. Epub 2005 May 4.

PMID:
15872045
3.

Variations in amino acid composition of antisense peptide-phosphorodiamidate morpholino oligomer affect potency against Escherichia coli in vitro and in vivo.

Mellbye BL, Puckett SE, Tilley LD, Iversen PL, Geller BL.

Antimicrob Agents Chemother. 2009 Feb;53(2):525-30. doi: 10.1128/AAC.00917-08. Epub 2008 Nov 17.

4.
6.

Inhibition of gene expression in Escherichia coli by antisense phosphorodiamidate morpholino oligomers.

Geller BL, Deere JD, Stein DA, Kroeker AD, Moulton HM, Iversen PL.

Antimicrob Agents Chemother. 2003 Oct;47(10):3233-9.

7.

Cationic phosphorodiamidate morpholino oligomers efficiently prevent growth of Escherichia coli in vitro and in vivo.

Mellbye BL, Weller DD, Hassinger JN, Reeves MD, Lovejoy CE, Iversen PL, Geller BL.

J Antimicrob Chemother. 2010 Jan;65(1):98-106. doi: 10.1093/jac/dkp392.

PMID:
19884121
8.
9.

Inhibition of intracellular growth of Salmonella enterica serovar Typhimurium in tissue culture by antisense peptide-phosphorodiamidate morpholino oligomer.

Mitev GM, Mellbye BL, Iversen PL, Geller BL.

Antimicrob Agents Chemother. 2009 Sep;53(9):3700-4. doi: 10.1128/AAC.00099-09. Epub 2009 Jul 6.

10.

Stability of cell-penetrating peptide-morpholino oligomer conjugates in human serum and in cells.

Youngblood DS, Hatlevig SA, Hassinger JN, Iversen PL, Moulton HM.

Bioconjug Chem. 2007 Jan-Feb;18(1):50-60.

PMID:
17226957
11.

Treatment of AG129 mice with antisense morpholino oligomers increases survival time following challenge with dengue 2 virus.

Stein DA, Huang CY, Silengo S, Amantana A, Crumley S, Blouch RE, Iversen PL, Kinney RM.

J Antimicrob Chemother. 2008 Sep;62(3):555-65. doi: 10.1093/jac/dkn221. Epub 2008 Jun 19.

PMID:
18567576
12.

Antisense phosphorodiamidate morpholino oligomers targeted to an essential gene inhibit Burkholderia cepacia complex.

Greenberg DE, Marshall-Batty KR, Brinster LR, Zarember KA, Shaw PA, Mellbye BL, Iversen PL, Holland SM, Geller BL.

J Infect Dis. 2010 Jun 15;201(12):1822-30. doi: 10.1086/652807.

13.

Arginine-rich peptide conjugation to morpholino oligomers: effects on antisense activity and specificity.

Nelson MH, Stein DA, Kroeker AD, Hatlevig SA, Iversen PL, Moulton HM.

Bioconjug Chem. 2005 Jul-Aug;16(4):959-66.

PMID:
16029037
14.

Cellular uptake of antisense morpholino oligomers conjugated to arginine-rich peptides.

Moulton HM, Nelson MH, Hatlevig SA, Reddy MT, Iversen PL.

Bioconjug Chem. 2004 Mar-Apr;15(2):290-9.

PMID:
15025524
15.

Cell-penetrating peptide-morpholino conjugates alter pre-mRNA splicing of DMD (Duchenne muscular dystrophy) and inhibit murine coronavirus replication in vivo.

Moulton HM, Fletcher S, Neuman BW, McClorey G, Stein DA, Abes S, Wilton SD, Buchmeier MJ, Lebleu B, Iversen PL.

Biochem Soc Trans. 2007 Aug;35(Pt 4):826-8. Review.

PMID:
17635157
16.

Arginine-rich cell-penetrating peptides facilitate delivery of antisense oligomers into murine leukocytes and alter pre-mRNA splicing.

Marshall NB, Oda SK, London CA, Moulton HM, Iversen PL, Kerkvliet NI, Mourich DV.

J Immunol Methods. 2007 Aug 31;325(1-2):114-26. Epub 2007 Jul 27.

PMID:
17673254
17.

Bacterial resistance to antisense peptide phosphorodiamidate morpholino oligomers.

Puckett SE, Reese KA, Mitev GM, Mullen V, Johnson RC, Pomraning KR, Mellbye BL, Tilley LD, Iversen PL, Freitag M, Geller BL.

Antimicrob Agents Chemother. 2012 Dec;56(12):6147-53. doi: 10.1128/AAC.00850-12. Epub 2012 Sep 17.

18.

Pharmacokinetics, biodistribution, stability and toxicity of a cell-penetrating peptide-morpholino oligomer conjugate.

Amantana A, Moulton HM, Cate ML, Reddy MT, Whitehead T, Hassinger JN, Youngblood DS, Iversen PL.

Bioconjug Chem. 2007 Jul-Aug;18(4):1325-31. Epub 2007 Jun 21.

PMID:
17583927
19.

Morpholino oligomers targeting the PB1 and NP genes enhance the survival of mice infected with highly pathogenic influenza A H7N7 virus.

Gabriel G, Nordmann A, Stein DA, Iversen PL, Klenk HD.

J Gen Virol. 2008 Apr;89(Pt 4):939-48. doi: 10.1099/vir.0.83449-0.

PMID:
18343835
20.

Inhibition of infectious haematopoietic necrosis virus in cell cultures with peptide-conjugated morpholino oligomers.

Alonso M, Stein DA, Thomann E, Moulton HM, Leong JC, Iversen P, Mourich DV.

J Fish Dis. 2005 Jul;28(7):399-410.

PMID:
16083445

Supplemental Content

Support Center